ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,793Medicare Part D Prescriptions Filled, Including Refills

Rank: 197 out of 972

$591K Total Retail Price of All Prescriptions

Rank: 227 out of 972

789 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 789 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 789 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,926 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 548 494 1 2
LOVASTATIN 534 469 2 22
AMLODIPINE BESYLATE 490 429 3 4
METFORMIN HCL 392 317 4 8
LEVOTHYROXINE SODIUM 369 345 5 3
LISINOPRIL 357 290 6 1
ATENOLOL 354 313 7 18
HYDROCHLOROTHIAZIDE 308 284 8 10
HYDROCODONE-ACETAMINOPHEN 261 159 S3 9 6
QUINAPRIL HCL 260 232 10 95
OMEPRAZOLE 247 204 11 5
FUROSEMIDE 193 167 12 7
GLIPIZIDE ER 189 174 13 103
ALENDRONATE SODIUM 182 182 14 27
ATORVASTATIN CALCIUM 178 153 15 11
METOPROLOL TARTRATE 174 134 16 9
WARFARIN SODIUM 159 152 17 12
KLOR-CON 10 158 141 18 68
ENALAPRIL MALEATE 150 133 19 50
METOPROLOL SUCCINATE 135 120 20 16
LANTUS 133 104 21 44
ZOLPIDEM TARTRATE 130 116 22 23
CARVEDILOL 129 106 23 21
GLIPIZIDE 123 108 24 59
CLOPIDOGREL 122 108 25 37
TRIAMTERENE-HCTZ 117 108 26 39
TRAMADOL HCL 112 100 27 15
SERTRALINE HCL 111 84 28 25
DIOVAN 107 101 29 48
FLUOXETINE HCL 100 79 30 60
ALLOPURINOL 98 85 31 28
GEMFIBROZIL 98 86 31 93
AMITRIPTYLINE HCL 95 78 R 33 58
POTASSIUM CHLORIDE 93 77 34 13
ZETIA 92 78 35 79
NAPROXEN 90 73 36 71
DONEPEZIL HCL 85 85 37 26
PLAVIX 73 68 38 55
INSULIN SYRINGE 69 53 39 84
SPIRIVA 67 60 40 56
ISOSORBIDE MONONITRATE ER 67 62 40 43
RANITIDINE HCL 67 57 40 24
GABAPENTIN 63 43 43 14
LOSARTAN POTASSIUM 62 58 44 17
CRESTOR 62 39 44 33
TRIAMTERENE-HYDROCHLOROTHIAZID 58 42 46 152
AMOX TR-POTASSIUM CLAVULANATE 58 52 46 157
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 48 48 32
NIFEDIPINE ER 55 44 49 116
GLYBURIDE 54 31 R 50 70
ADVAIR DISKUS 54 42 50 45
METFORMIN HCL ER 53 50 52 62
LANTUS SOLOSTAR 52 48 53 86
IBUPROFEN 52 36 53 92
PRAVASTATIN SODIUM 50 49 55 20
BENICAR 50 48 55 133
VERAPAMIL ER 50 50 55 108
PANTOPRAZOLE SODIUM 50 43 55 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.